Loading clinical trials...
Loading clinical trials...
We will address the hypothesis that refractory ascites and Type 2 hepatorenal syndrome are mediated in part by diminished circulatory volume and that treatment with midodrine, octreotide and albumin c...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Alberta
Collaborators
NCT06814626 · Liver Cirrhosis, Refractory Ascites in Patients with Cirrhosis, and more
NCT05700708 · Cirrhosis, Liver, Acute-On-Chronic Liver Failure, and more
NCT05434286 · Hepatorenal Syndrome, Cirrhosis, Liver, and more
NCT04043858 · Refractory Ascites, Children, Only
University of Alberta
Edmonton, Alberta
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions